Breaking News

EXO Biologics Launches New CDMO Specializing in Exosomes

ExoXpert will operate the ExoPulse platform to serve demand from exosome developers for R&D-grade exosome vials as well as GMP manufacturing capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

EXO Biologics SA, a Belgian biotech company committed to developing biopharmaceuticals using exosomes to treat rare diseases with high unmet medical needs, has launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes.   ExoXpert offers an MSC-based exosome manufacturing platform used in European clinical trials and is a wholly owned subsidiary of EXO Biologics. Serving Demand from Exosome Developers with the ExoPulse Platform During the deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters